The Bank of New York Mellon Corporation Price & Performance (BK)

Bank of New York Mellon Corp increased its stake in Rocket Pharmaceuticals by 5.4% during the fourth quarter, acquiring an additional 9,949 shares. With 194,182 shares now held, the investment is valued at $2.44 million. This move reflects a growing interest in the biotechnology sector among institutional investors.1

Castellum, Inc.'s shares dropped 4.7% to $1.22, following mixed news. Bank of New York Mellon Corp acquired 1.76% of the company, while insider Mark C. Fuller sold 275,000 shares. The transaction reduced his stake by 3.61%. Castellum's stock remains volatile, with a 52-week range of $0.12 to $2.83.2

Bank of New York Mellon Corp reduced its Amplify Energy holdings by 3% in Q4, selling 12,672 shares. The institutional investor now owns 405,503 shares, valued at $2.43 million. Other major investors, including Sanctuary Advisors and Rhumbline Advisers, have also adjusted their positions in the company.3